FilingReader Intelligence

AstraZeneca India reports 32% revenue growth, appoints new MD

July 22, 2025 at 01:19 PM UTC•By FilingReader AI

AstraZeneca Pharma India Limited reported total income of ₹17,569.2 million and profit after tax of ₹1,157.4 million for FY2024-25, representing 32% year-on-year revenue growth.

The board recommended a dividend of ₹32 per equity share.

The company appointed Praveen Rao Akkinepally as managing director, effective July 1, 2025, and re-appointed Hooi Bien Chuah as director.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Please find the enclosed copy of the Annual Report for the financial year 2024-25 for your reference.July 22, 2025 at 01:04 PM UTC

Supplementary Source Documents

Please find the enclosed Notice of the AGM scheduled to be held on Thursday, August 14, 2025 at 3:00 p.m. IST.July 22, 2025 at 01:09 PM UTC

AstraZeneca Pharma India

BSE:ASTRAZEN•Bombay Stock Exchange

RSS feed for AstraZeneca Pharma India

News Alerts

Get instant email alerts when AstraZeneca Pharma India publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →